Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00541892

Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

Sibling Oocyte Study of Medium for IVF/ICSI With no Human Serum Albumine

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Sykehuset Telemark · Other Government
Sex
All
Age
18 Years – 38 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Detailed description

Cells attained in IVF/ICSI procedures are kept in a medium that nurture the cells. Until now all such media have contained human serum albumine. The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Conditions

Interventions

TypeNameDescription
OTHERMedium with no human serum albumine addedSee above
OTHERConventional mediumSee above

Timeline

Start date
2007-09-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2007-10-10
Last updated
2015-05-20

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00541892. Inclusion in this directory is not an endorsement.

Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Seru (NCT00541892) · Clinical Trials Directory